title: Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
abstract: The RSH/Smith-Lemli-Opitz syndrome (SLOS) is a multiple malformation/mental retardation syndrome caused by an inborn error of cholesterol synthesis. Mutations in the 3beta-hydroxysteroid Delta(7)-reductase gene result in impaired enzymatic reduction of 7-dehydrocholesterol (7-DHC) to cholesterol. Cells obtain cholesterol by either de novo synthesis or from exogenous sources by the binding and uptake of low density lipoprotein (LDL) particles. Because de novo synthesis of cholesterol is impaired in SLOS, current investigational therapy for SLOS consists of dietary cholesterol supplementation. However, the potential effects of elevated intracellular levels of 7-DHC on intracellular LDL metabolism have not been described. We now report that in addition to the primary defect in de novo cholesterol synthesis, SLOS fibroblasts have a secondary defect of LDL cholesterol metabolism. Staining of fibroblasts with filipin, a fluorescent polyene antibiotic which binds unesterified sterols, shows that SLOS fibroblasts accumulate unesterified sterols. Further studies show that this increased filipin staining was due to an abnormal accumulation of LDL derived cholesterol rather than due to storage of endogenously synthesized 7-dehydrocholesterol (7-DHC). We have also found that SLOS fibroblasts failed to degrade LDL at a normal rate, and examination of SLOS fibroblasts by electron microscopy demonstrated the formation of lysosomal inclusions similar to that seen in Niemann-Pick type C (NPC) cells. We propose that 7-DHC may directly or indirectly inhibit the function of the NPC protein through its sterol-sensing domain (SSD), and that 7-DHC may perturb the function of other SSD containing proteins in SLOS.
authors.affiliation: Unit on Molecular Dysmorphology, Heritable Disorders Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Wassif
authors.forename: Donna
authors.initials: D
authors.lastname: Vied
authors.forename: Maria
authors.initials: M
authors.lastname: Tsokos
authors.forename: William E
authors.initials: WE
authors.lastname: Connor
authors.forename: Robert D
authors.initials: RD
authors.lastname: Steiner
authors.forename: Forbes D
authors.initials: FD
authors.lastname: Porter
mesh_terms: D002460:Cell Line; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D003684:Dehydrocholesterols / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism* / Q000473:pathology; D005372:Filipin / Q000378:metabolism; D006801:Humans; D002479:Inclusion Bodies; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008247:Lysosomes; D008854:Microscopy, Electron; D012867:Skin; D019082:Smith-Lemli-Opitz Syndrome / Q000378:metabolism* / Q000473:pathology; D013194:Staining and Labeling / Q000379:methods
chemical_list: D003684:Dehydrocholesterols; D008077:Lipoproteins, LDL; D005372:Filipin; D002784:Cholesterol; C016705:7-dehydrocholesterol